儿童和青少年治疗甲基胺治疗注意力缺陷多动性障碍的体重指数变化
Maryam Kousha1, Samaneh Hasanpour Asli1, Fatemeh Eslamdoust-Siahestalkhi1
1Kavosh Cognitive Behavior Sciences and Addiction Research Center, Department of Psychiatry, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Iranian journal of child neurology
|April 15, 2024
概括
长期使用ADHD药物可能会增加儿童肥胖的风险. 延长的甲基胺治疗与儿童患者的更高的身体质量指数增加相关.
科学领域:
- 儿科健康 儿科健康
- 神经发育障碍 神经发育障碍
- 代谢健康 代谢健康
背景情况:
- 注意缺陷多动性障碍 (ADHD) 和肥胖症是儿童的重大公共卫生问题.
- 研究ADHD和肥胖之间的关系对于理解和管理儿童这些疾病至关重要.
研究的目的:
- 检查儿童群体中注意力缺陷多动症 (ADHD) 和身体质量指数 (BMI) 变化之间的联系.
- 确定甲基胺治疗的持续时间是否会影响被诊断为ADHD的儿童的BMI变化.
主要方法:
- 一项回顾性队列研究,涉及149名被诊断患有ADHD的儿童和青少年 (3-18岁).
- 参与者接受了甲基酸盐治疗,并跟踪了他们的身高,体重和BMI.
- 用描述性统计,重复测量和威尔克斯的lambda分析来分析数据.
主要成果:
- 甲基胺治疗时间较长与BMI增加显著相关 (p <0.001).
- 体重指数 (BMI) 的变化与治疗开始时的年龄没有显著关系 (p = 0.125).
- 根据性别,多动症特征或同时服用的药物,没有观察到BMI变化的显著差异.
结论:
- 研究结果表明,长期使用ADHD药物与儿童肥胖风险增加之间存在潜在联系.
- 延长的甲基胺治疗可能会导致儿童ADHD患者的BMI增加.
相关概念视频
Attention-Deficit/Hyperactivity Disorder
57
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
57
Adrenergic Agonists: Mixed-Action Agents
706
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
706
Antiasthma Drugs: Methylxanthines
221
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
221
Insulin: Dosing Regimen and Adverse Effects
169
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
169
Adrenergic Agonists: Therapeutic Uses
770
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
770
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K


